Ayurvedic managment of tubal blockage
- Conditions
- Female pelvic inflammatory disorders in diseases classified elsewhere,
- Registration Number
- CTRI/2020/03/024132
- Lead Sponsor
- Institute for post gradute teaching and research in ayurveda gujarat ayurved university jamnagar
- Brief Summary
- Fallopian tubes not mentioned directly in Ayurvedic texts, are included under the heading of*Artava vaha srotasa*and Fallopian tube blockage can be correlated with *Artava vaha Srotodushti* mainly *Sanga* type. It is part of the *kshetra* and essential for conception.Artava vaha srotasa covers all the physiological, functional and anatomical structures of female reproduction. Tubal blockage can be the consequence of various gynaecological disorders like: *Yonivyapad, Artavadushti, Ashrigdara*and *Upadamsha*.In modern the major cause of infertility related to tube prior PID,TB, Abortions, D&C / D&E. the main complication of the tubal blockage is female infertility which was found 25-35% similar to that of demographic data as mention in current scenario. *Apamarga Kshara Taila removes the blockage by* its *Lekhana*(scraping) property, *Phalakalyana Ghrita* for *Ropana-*re establish the function of (ciliary movement) fallopian tube by its ropana property and *Ashwagandha churna helps in conception by balancing hormonal cycle*. 
 - 60% results was found in opening of the tube.
 - 33.33% results was found in conception.
 - 100% results was found in *Alpartava* (scanty menses)
 - 87.5% results was found in *Yonivedana* (dysmenorrhoea)
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 10
1patient with active marital life more than 1 year but failed to conceive with at least one fallopian tube blockage diagnosed by HSG and by any other methods 2Patient suitable for Virechana Niruhabasti and Uttarabasti.
1 Patients having age group below 20 years and above 37 years 2 Patients having Carcinoma of reproductive tract 3 Patients having active inflammatory disease eg acute PID STD like HIV VDRL HBsAg HCV and TORCH positive 4 Patient having Congenital anomaly of reproductive tract 5 Patients having uncontrolled Hypertension DM and any other severe systemic disease 6 Women with Hb less than 7 gm% 7 Patients not suitable for Virechana Niruhabasti and Uttarabasti.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Opening of the Fallopian Tube - 40 DAYS 
- Secondary Outcome Measures
- Name - Time - Method - Conception - Effect of Therapy in Menstrual Pathology i e Dysmenorrhoea Irregular Menses Oligomenorrhoea Endometrial Thickness 
Trial Locations
- Locations (1)
- Institute for post gradute teaching and research in ayurveda 🇮🇳- Jamnagar, GUJARAT, India Institute for post gradute teaching and research in ayurveda🇮🇳Jamnagar, GUJARAT, IndiaEktaben VaddoriyaPrincipal investigator8487069680dr.ektavaddoriya@gmail.com
